FreshAir, an industry leader in the development of sensors to detect and alert for hazardous chemicals, announces that it has been awarded a Fast-Track Phase II grant totaling over $1.2 million from the National Institute on Drug Abuse, part of the National Institutes of Health. The eighteen-month grant follows FreshAir’s successful completion of milestones for the Fast-Track Phase I grant received in September 2019 and will support development of effective vaping sensors for use in schools and other environments.
“We are accelerating the development of our sensors specific to the molecules released during e-cigarette vaping,” said Joseph BelBruno, Chief Technology Officer of FreshAir.
FreshAir already offers the market’s only technology to monitor for, immediately detect, and scientifically prove tobacco smoking and marijuana smoking. The company is continuing to improve upon its patented PolySens® polymer sensor technology in order to detect and prove e-cigarette vaping.
“Our mission as a company is to ‘improve lives through novel sensor technology,’ and our objectives with this grant are to help schools reduce the incidence of vaping and improve youth health outcomes,” BelBruno added.